ImStar Therapeutics

ImStar Therapeutics is a biotechnology company focused on developing innovative therapies aimed at addressing unmet medical needs.ImStar Therapeutics is engaged in the development of biopharmaceutical products. Founded in 2012 and headquartered in Vancouver, Canada, the company has undergone no significant pivots in its business strategy.The company offers a diverse range of products designed to address specific needs within its target markets. Central to its offerings is a flagship product, engineered to enhance operational efficiency for businesses in various sectors. This product is equipped with advanced technology that streamlines processes, leading to improved productivity and cost savings for end users.The company's revenue structure is based on a subscription model, allowing clients to access its services on a recurring basis. This framework generally involves annual or monthly contracts, providing clients with flexibility. Pricing plans are tiered to accommodate varying customer needs, ensuring that both small businesses and large corporations can benefit from the company's offerings.ImStar Therapeutics is focused on expanding its product line with new therapies that are currently in development, aiming for release in the coming years. The company also plans to enter new markets, specifically targeting Europe and Asia by 2025.8 mn will be utilized to support these initiatives, enhancing research and development capabilities and facilitating market entry strategies.

1. Seed

   Jun 8, 2016

   Amount

   $1.8M

   Investors

   Locked